Cargando…
Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway
BACKGROUND: Aberrant activation of Wnt/β-catenin signaling promotes the development of several cancers. It has been demonstrated that the Wnt signaling pathway is activated in chronic lymphocytic leukemia (CLL) cells, and that uncontrolled Wnt/β-catenin signaling may contribute to the defect in apop...
Autores principales: | Lu, Desheng, Liu, Jerry X., Endo, Tomoyuki, Zhou, Haowen, Yao, Shiyin, Willert, Karl, Schmidt-Wolf, Ingo G. H., Kipps, Thomas J., Carson, Dennis A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789382/ https://www.ncbi.nlm.nih.gov/pubmed/20011538 http://dx.doi.org/10.1371/journal.pone.0008294 |
Ejemplares similares
-
Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation
por: Zhang, Xuehui, et al.
Publicado: (2021) -
Transscleral diffusion of ethacrynic acid and sodium fluorescein
por: Lin, Cheng-Wen, et al.
Publicado: (2007) -
Ethacrynic acid is an inhibitor of human factor XIIIa
por: Kar, Srabani, et al.
Publicado: (2022) -
High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid
por: Wu, Wei, et al.
Publicado: (2016) -
Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β-catenin signaling
por: Sun, Qi, et al.
Publicado: (2019)